Acasti Pharma Inc (ACST)
2.78
+0.10
(+3.73%)
USD |
NASDAQ |
Apr 30, 16:00
2.78
0.00 (0.00%)
After-Hours: 20:00
Acasti Pharma Cash and Short Term Investments (Quarterly): 25.11M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 25.11M |
| September 30, 2023 | 27.01M |
| June 30, 2023 | 21.65M |
| March 31, 2023 | 27.89M |
| December 31, 2022 | 31.26M |
| September 30, 2022 | 34.94M |
| June 30, 2022 | 38.39M |
| March 31, 2022 | 43.66M |
| December 31, 2021 | 46.32M |
| September 30, 2021 | 50.79M |
| June 30, 2021 | 57.72M |
| March 31, 2021 | 60.73M |
| December 31, 2020 | 27.92M |
| September 30, 2020 | 11.55M |
| June 30, 2020 | 12.12M |
| March 31, 2020 | 14.24M |
| December 31, 2019 | 19.68M |
| September 30, 2019 | 19.52M |
| June 30, 2019 | 19.35M |
| March 31, 2019 | 25.76M |
| December 31, 2018 | 33.51M |
| September 30, 2018 | 4.620M |
| June 30, 2018 | 9.778M |
| March 31, 2018 | 6.368M |
| December 31, 2017 | 9.920M |
| Date | Value |
|---|---|
| September 30, 2017 | 4.296M |
| June 30, 2017 | 5.818M |
| November 30, 2016 | 4.349M |
| August 31, 2016 | 5.442M |
| May 31, 2016 | 5.817M |
| February 29, 2016 | 7.726M |
| November 30, 2015 | 10.54M |
| August 31, 2015 | 11.91M |
| May 31, 2015 | 13.86M |
| February 28, 2015 | 14.69M |
| November 30, 2014 | 17.13M |
| August 31, 2014 | 19.48M |
| May 31, 2014 | 21.14M |
| February 28, 2014 | 21.30M |
| November 30, 2013 | 3.388M |
| August 31, 2013 | 3.761M |
| May 31, 2013 | 3.742M |
| February 28, 2013 | 4.674M |
| November 30, 2012 | 4.620M |
| August 31, 2012 | 5.195M |
| May 31, 2012 | 6.330M |
| February 29, 2012 | 7.174M |
| November 30, 2011 | 6.209M |
| August 31, 2011 | 1.872M |
| May 31, 2011 | 2.480M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
11.55M
Minimum
Sep 2020
60.73M
Maximum
Mar 2021
31.04M
Average
27.89M
Median
Mar 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | 350.49M |
| Edesa Biotech Inc | 4.268M |
| Lexaria Bioscience Corp | 4.793M |
| Xenon Pharmaceuticals Inc | 638.08M |
| ESSA Pharma Inc | 142.12M |